IRIS International, Inc. (Nasdaq: IRIS), reports it is restructuring its Personalized Medicine division by downsizing and consolidating Arista Molecular's operations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE